bf/NASDAQ:FENC_icon.jpeg

NASDAQ:FENC

Fennec Pharmaceuticals Inc.

  • Stock

USD

Last Close

10.02

14/05 20:00

Market Cap

263.68M

Beta: 0.16

Volume Today

1.10M

Avg: 80.91K

PE Ratio

−11.72

PFCF: −16.43

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
288K
-
1.36M
372.39%
average payables
235.50K
-
260K
10.40%
302.50K
16.35%
270.50K
10.58%
549.50K
103.14%
943.50K
71.70%
1.32M
40.12%
1.59M
20.39%
1.17M
26.23%
1.58M
34.88%
3.08M
94.81%
average receivables
772.50K
-
5.16M
567.57%
book value per share
-0.15
-
0.06
141.48%
0.05
18.50%
0.28
452.55%
1.78
537.23%
1.12
37.11%
0.59
46.92%
1.23
106.14%
0.61
50.55%
-0.10
116.12%
-0.44
345.02%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share
0.17
-
0.23
36.59%
0.09
62.77%
0.31
253.50%
1.88
511.99%
1.20
36.35%
0.68
42.92%
1.28
87.20%
0.81
36.62%
0.90
11.52%
0.50
45.10%
days of inventory on hand
2.44K
-
610.66
75.02%
days payables outstanding
10.14K
-
1.08K
89.39%
days sales outstanding
367.38
-
147.89
59.74%
debt to assets
0.22
-
0.92
315.33%
1.11
19.67%
debt to equity
0.32
-
-9.69
3,164.63%
-2.56
73.62%
dividend yield
earnings yield
0.06
-
-0.08
233.39%
-0.03
57.42%
-0.10
192.78%
-0.05
54.16%
-0.08
74.02%
-0.10
18.01%
-0.10
5.52%
-0.15
50.32%
-0.10
35.45%
-0.05
44.35%
enterprise value
28.37M
-
24.25M
14.53%
17.94M
26.00%
23.37M
30.26%
122.18M
422.76%
98.54M
19.35%
115.90M
17.62%
146.25M
26.19%
98.31M
32.78%
253.37M
157.71%
314.52M
24.14%
enterprise value over ebitda
-14.68
-
-6.78
53.82%
-5.75
15.13%
-7.90
37.26%
-17.92
126.91%
-9.32
48.02%
-8.91
4.38%
-8.13
8.72%
-5.72
29.65%
-11.24
96.46%
-24.18
115.18%
ev to operating cash flow
-12.84
-
-14.27
11.17%
-9.64
32.48%
-11.00
14.19%
-33.56
204.96%
-12.59
62.48%
-12.79
1.60%
-9.38
26.69%
-6.91
26.29%
-14.03
102.96%
ev to sales
860.30
-
165.06
-
14.53
91.20%
free cash flow per share
-0.23
-
-0.17
24.31%
-0.17
0.08%
-0.17
3.25%
-0.24
45.74%
-0.41
69.71%
-0.45
10.28%
-0.66
44.95%
-0.55
16.88%
-0.69
25.67%
free cash flow yield
-0.07
-
-0.06
13.05%
-0.10
54.10%
-0.08
21.09%
-0.02
68.89%
-0.06
166.54%
-0.07
8.41%
-0.09
26.27%
-0.12
40.74%
-0.07
42.40%
graham net net
-0.16
-
0.06
134.95%
0.04
21.64%
0.28
534.60%
1.77
542.14%
1.11
37.28%
0.57
48.73%
1.18
107.19%
0.56
52.93%
-0.16
129.35%
-0.66
302.18%
graham number
0.80
-
0.55
30.60%
0.26
52.56%
1.17
345.36%
4.34
269.96%
3.62
16.52%
2.89
20.18%
4.57
58.02%
3.03
33.74%
1.44
52.35%
2.45
70.13%
income quality
-1.20
-
0.78
165.18%
2.83
261.88%
0.76
73.05%
0.52
32.15%
0.79
53.16%
0.71
10.39%
0.86
21.43%
0.82
4.79%
0.76
7.12%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-1.44K
-
-136.69
-
-23.10
83.10%
-3.47
84.98%
interest debt per share
0.00
-
0.20
-
0.98
400.82%
1.25
27.28%
inventory turnover
0.15
-
0.60
300.33%
invested capital
0.32
-
-9.69
3,164.63%
-2.56
73.62%
market cap
30.03M
-
26.55M
11.58%
18.88M
28.88%
27.30M
44.55%
150.44M
451.10%
121.32M
19.36%
129.55M
6.78%
176.59M
36.32%
114.43M
35.20%
252.24M
120.44%
298.16M
18.20%
net current asset value
-1.46M
-
613K
142.13%
548K
10.60%
3.57M
551.46%
26.76M
649.50%
21.31M
20.35%
11.61M
45.51%
29.07M
150.32%
15.74M
45.84%
-2.78M
117.66%
-13.57M
388.24%
net debt to ebitda
0.86
-
0.65
25.05%
0.30
53.17%
1.33
339.17%
4.15
212.44%
2.15
48.04%
1.05
51.29%
1.69
60.80%
0.94
44.43%
-0.05
105.32%
-1.26
2,420.86%
net income per share
0.19
-
-0.22
216.12%
-0.06
72.39%
-0.22
258.96%
-0.47
114.79%
-0.52
10.80%
-0.62
20.04%
-0.76
21.12%
-0.67
11.22%
-0.95
40.84%
-0.61
34.96%
operating cash flow per share
-0.23
-
-0.17
24.31%
-0.17
0.08%
-0.17
3.25%
-0.24
45.74%
-0.41
69.71%
-0.45
10.28%
-0.66
44.95%
-0.55
16.88%
-0.69
25.67%
payables turnover
0.04
-
0.34
842.70%
receivables turnover
0.99
-
2.47
148.41%
research and ddevelopement to revenue
30.03
-
2.30
-
0.00
99.89%
return on tangible assets
1.05
-
-0.92
187.11%
-0.65
29.50%
-0.70
8.57%
-0.25
64.67%
-0.43
73.67%
-0.88
104.44%
-0.57
35.24%
-0.78
36.52%
-0.92
18.39%
-0.61
33.70%
revenue per share
0.01
-
0.06
-
0.81
1,294.02%
roe
-1.27
-
-3.55
179.94%
-1.20
66.12%
-0.78
35.04%
-0.26
66.29%
-0.46
76.18%
-1.05
126.16%
-0.62
41.24%
-1.11
79.52%
9.67
973.60%
1.41
85.38%
roic
1.33
-
-4.69
452.93%
-3.43
26.78%
-0.80
76.64%
-0.26
67.82%
-0.47
82.60%
-1.07
126.76%
-0.61
43.01%
-0.83
37.12%
-1.06
26.91%
-0.72
31.81%
sales general and administrative to revenue
76.18
-
11.55
-
shareholders equity per share
-0.15
-
0.06
141.48%
0.05
18.50%
0.28
452.55%
1.78
537.23%
1.12
37.11%
0.59
46.92%
1.23
106.14%
0.61
50.55%
-0.10
116.12%
-0.44
345.02%
stock based compensation to revenue
16.42
-
2.66
-
tangible asset value
-1.46M
-
613K
142.13%
548K
10.60%
3.57M
551.46%
26.76M
649.50%
21.31M
20.35%
11.88M
44.28%
29.07M
144.80%
15.77M
45.74%
-2.57M
116.29%
-11.56M
350.08%
tangible book value per share
-0.15
-
0.06
141.48%
0.05
18.50%
0.28
452.55%
1.78
537.23%
1.12
37.11%
0.59
46.92%
1.23
106.14%
0.61
50.55%
-0.10
116.12%
-0.44
345.02%
working capital
-1.46M
-
613K
142.13%
548K
10.60%
3.57M
551.46%
26.76M
649.50%
21.31M
20.35%
11.61M
45.51%
29.07M
150.32%
20.73M
28.68%
22.12M
6.68%
17.20M
22.23%

All numbers in USD (except ratios and percentages)